Suppr超能文献

晚期喉癌的治疗并发症与生存率:一项基于人群的分析。

Treatment complications and survival in advanced laryngeal cancer: a population-based analysis.

作者信息

O'Neill Caitriona B, O'Neill James P, Atoria Coral L, Baxi Shrujal S, Henman Martin C, Ganly Ian, Elkin Elena B

机构信息

Center for Health Policy and Outcomes, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, Ireland; School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin, Ireland.

出版信息

Laryngoscope. 2014 Dec;124(12):2707-13. doi: 10.1002/lary.24658. Epub 2014 Oct 4.

Abstract

OBJECTIVES/HYPOTHESIS: Primary curative treatment of advanced laryngeal cancer may include surgery or chemoradiation, although recommendations vary and both are associated with complications. We evaluated predictors and trends in the use of these modalities and compared rates of complications and overall survival in a population-based cohort of older adults.

STUDY DESIGN

Retrospective population-based cohort study.

METHODS

Using Surveillance Epidemiology and End Results (SEER) cancer registry data linked with Medicare claims, we identified patients over 65 with advanced laryngeal cancer diagnosed 1999 to 2007 who had total laryngectomy (TL) or chemoradiation (CTRT) within 6 months following diagnosis. We identified complications and estimated the impact of treatment on overall survival, using propensity score methods.

RESULTS

The proportion of patients receiving TL declined from 74% in 1999 to 26% in 2007 (P < 0.0001). Almost 20% of the CTRT patients had a tracheostomy following treatment, and 57% had a feeding tube. TL was associated with an 18% lower risk of death, adjusting for patient and disease characteristics. The benefit of TL was greatest in patients with the highest propensity to receive surgery.

CONCLUSION

TL remains an important treatment option in well selected older patients. However, treatment selection is complex; and factors such as functional status, patient preference, surgeon expertise, and post-treatment support services should play a role in treatment decisions.

LEVEL OF EVIDENCE

2b. Laryngoscope, 124:2707-2713, 2014.

摘要

目的/假设:晚期喉癌的主要根治性治疗方法可能包括手术或放化疗,尽管相关建议存在差异,且两种方法都伴有并发症。我们评估了这些治疗方式使用情况的预测因素和趋势,并比较了基于人群队列的老年患者的并发症发生率和总生存率。

研究设计

基于人群的回顾性队列研究。

方法

利用与医疗保险索赔数据相链接的监测、流行病学和最终结果(SEER)癌症登记数据,我们确定了1999年至2007年诊断为晚期喉癌且在诊断后6个月内接受全喉切除术(TL)或放化疗(CTRT)的65岁以上患者。我们确定了并发症,并使用倾向评分方法估计了治疗对总生存率的影响。

结果

接受TL治疗的患者比例从1999年的74%降至2007年的26%(P < 0.0001)。近20%的CTRT患者在治疗后进行了气管造口术,57%的患者使用了饲管。在对患者和疾病特征进行调整后,TL与死亡风险降低18%相关。TL的益处对于接受手术倾向最高的患者最为显著。

结论

对于精心挑选的老年患者,TL仍然是一种重要的治疗选择。然而,治疗选择很复杂;功能状态、患者偏好、外科医生专业知识和治疗后支持服务等因素应在治疗决策中发挥作用。

证据水平

2b。《喉镜》,124:2707 - 2713,2014年。

相似文献

2
Short- and long-term outcomes of laryngeal cancer care in the elderly.老年喉癌患者治疗的短期和长期结果
Laryngoscope. 2015 Apr;125(4):924-33. doi: 10.1002/lary.25012. Epub 2014 Nov 4.
4
Supraglottic laryngeal cancer: analysis of treatment results.声门上型喉癌:治疗结果分析
Laryngoscope. 2005 Aug;115(8):1402-10. doi: 10.1097/01.MLG.0000166896.67924.B7.
6
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
7
Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.同步放化疗在晚期(T4)喉癌中的应用。
Am J Otolaryngol. 2017 Jan-Feb;38(1):72-76. doi: 10.1016/j.amjoto.2016.10.001. Epub 2016 Oct 5.

引用本文的文献

2
[Clinical treatment strategy for pT3N0 laryngeal squamous cell carcinoma].[pT3N0期喉鳞状细胞癌的临床治疗策略]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Jan;39(1):61-65. doi: 10.13201/j.issn.2096-7993.2025.01.013.

本文引用的文献

6
Controversies in the locoregional management of head and neck cancer.头颈部癌症的局部区域治疗争议。
J Natl Compr Canc Netw. 2011 Jun 1;9(6):653-62. doi: 10.6004/jnccn.2011.0054.
9
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验